Muthi' Ikawati

9PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesHaematological tumoursGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 29, 2026
Agarose-Based 3D Spheroid Model to Evaluate the Anticancer Activity of the Curcumin Analog CCA-1.1 in Triple-Negative Breast Cancer.

|Sep 09, 2025
Inhibitory Effects of Citrus-Derived Flavonoids Hesperidin and Hesperetin on SARS-CoV-2 Spike-Mediated Syncytia Formation Using In Vitro Cell Model.

Dennaya Kumara, Hayfa Salsabila Harsan, Endah Puji Septisetyani

|Dec 04, 2024
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies.

Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato

|Nov 04, 2024
PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.

Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari

|Jun 17, 2024
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review.

Hui-Yin Yow, Muthi Ikawati, Soni Siswanto

|May 09, 2024
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments.

Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri

Pageof 2

Frequent Collaborators

4 joint publications

Edy Meiyanto

4 joint publications

Adam Hermawan

2 joint publications

Rohmad Yudi Utomo

2 joint publications

Riris Istighfari Jenie